Literature DB >> 8110208

Radiosurgery for venous angiomas.

C Lindquist1, W Y Guo, B Karlsson, L Steiner.   

Abstract

Radiosurgical treatment with the gamma knife for venous angiomas was used as an alternative to microsurgical removal in order to avoid abrupt cessation of venous drainage, which may be shared by the venous angioma and important parts of the brain. Thirteen cases of venous angioma were treated between 1977 and 1991. In two cases cavernous angiomas were also present and in one case a distant arteriovenous malformation (AVM) was also found. In two cases the angioma shared the venous drainage with an adjoining AVM; this is the first description of such pathology. For venous angiomas irradiation was prescribed to cover at least the convergence of the medullary veins. For AVM's close to a venous angioma the treatment was exclusively prescribed to the AVM nidus. After treatment, complete obliteration of the venous angioma was observed in one case, partial obliteration was observed in three cases, and five venous angiomas were unaffected by the treatment. Undue effects of radiation occurred in four cases: one focal edema and three radionecroses. Extirpation of the radionecrotic tissue 6 months after radiosurgery was necessary in one case. In the other three cases, the venous angioma was observed to be completely or partially obliterated, or unaffected by the treatment (one case each). In two cases of combined AVM and venous angioma, complete obliteration of the treatment AVM nidus was obtained. It is concluded that radiosurgery for venous angioma, although conceptually attractive, still does not fulfill the rigid criteria of minimal risk which must be set for the treatment of a lesion with a benign natural history.

Entities:  

Mesh:

Year:  1993        PMID: 8110208     DOI: 10.3171/jns.1993.78.4.0531

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

Review 1.  Cerebral developmental venous anomalies.

Authors:  Diego San Millán Ruíz; Philippe Gailloud
Journal:  Childs Nerv Syst       Date:  2010-08-12       Impact factor: 1.475

2.  Cerebral venous malformation complicated by spontaneous thrombosis.

Authors:  P Kim; R Castellani; N Tresser
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

Review 3.  Intracerebral haemorrhage.

Authors:  J M MacKenzie
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

4.  Isolated developmental venous anomaly of the pons with transpontine drainage: case report.

Authors:  Y T Yamgoue Tchameni; M Messerer; J B Zerlauth; M Levivier; R T Daniel
Journal:  Clin Neuroradiol       Date:  2013-02-09       Impact factor: 3.649

5.  Venous angiomas.

Authors:  Sepideh Amin-Hanjani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-06

6.  Radiosurgery with the first Austrian cobalt-60 Gamma-unit. A one year experience.

Authors:  G Pendl; O Schröttner; G M Friehs; J Legat; K Leber; M Mokry; G Papaefthymiou; G Langmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Diagnosis and treatment of vascular malformations of the brain.

Authors:  Bradley A Gross; Rose Du
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

8.  Spontaneous intracerebral hemorrhage caused by an unusual association of developmental venous anomaly and arteriovenous malformation.

Authors:  K F Fok; S Holmin; H Alvarez; A Ozanne; T Krings; P L Lasjaunias
Journal:  Interv Neuroradiol       Date:  2006-07-31       Impact factor: 1.610

9.  Neurovascular radiosurgery.

Authors:  M Söderman; W Y Guo; B Karlsson; D M Pelz; E Ulfarsson; T Andersson
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

10.  Developmental venous anomaly (DVA) with arterial component: a rare cause of intracranial haemorrhage.

Authors:  Ismail Oran; Yilmaz Kiroglu; Alaattin Yurt; Fisun Demircivi Ozer; Feridun Acar; Tayfun Dalbasti; Baki Yagci; Akif Sirikci; Cem Calli
Journal:  Neuroradiology       Date:  2008-09-12       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.